等待开盘 02-05 09:30:00 美东时间
-0.390
-7.78%
Atlas Lithium Corporation (NASDAQ:ATLX) ("Atlas Lithium" or "Company"), a leading lithium exploration and development company, is pleased to announce that its subsidiary, Atlas Critical Minerals Corporation ("Atlas
01-14 21:39
As previously disclosed, Atlas Lithium Corporation (the "Company") entered into that certain At The Market Offering Agreement, dated November 22, 2024 (the "Agreement") with H.C. Wainwright & Co., LLC, as sales agent
2025-12-13 05:38
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
HC Wainwright & Co. analyst Heiko F. Ihle maintains Atlas Lithium (NASDAQ:ATLX) with a Buy and lowers the price target from $18 to $12.
2025-11-17 19:44
Atlas Lithium (NASDAQ:ATLX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.64) by 45.31 percent. This is a 41.67 percent increase over losses of $(0.60) per share from the
2025-11-14 06:17
Gainers Electra Battery Materials (NASDAQ:ELBM) stock increased by 10.4% to $2...
2025-10-16 05:06
Strategic Partnership Model Allows for Near-Term Cash Flow GenerationBoca Raton, Florida--(Newsfile Corp. - September 2, 2025) - Atlas Lithium Corporation (NASDAQ:ATLX) ("Atlas Lithium" or "Company"), a leading lithium
2025-09-02 20:12
Atlas Lithium Corporation (NASDAQ:ATLX) ("Atlas Lithium" or "Company"), a leading lithium development company, is pleased to announce exceptional exploration results from its 100%-owned Salinas Project in Brazil's
2025-08-18 18:16
Atlas Lithium shares are trading higher after the company reported a Q2 EPS bea...
2025-08-04 23:41
Atlas Lithium (NASDAQ:ATLX) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.59) by 47.46 percent. This is a 53.73 percent increase over losses of $(0.67) per share from the
2025-08-04 21:23